|本期目录/Table of Contents|

[1]唐珑,王悦芬,赵文景,等.保肾通络方对早期糖尿病肾病大鼠尿蛋白及尿Nephrin、Podocin排泄的影响[J].环球中医药,2017,10(12):1423-1427.[doi:10.3969/j.issn.1674-1749.2017.12.002]
　TANG Long,WANG Yuefen,ZHAO Wenjing,et al.Effects of Baoshen Tongluo recipe on urinary albumin and urinary nephrin、podocin excretion in early diabetic nephropathy rats[J].,2017,10(12):1423-1427.[doi:10.3969/j.issn.1674-1749.2017.12.002]
点击复制

保肾通络方对早期糖尿病肾病大鼠尿蛋白及尿Nephrin、Podocin排泄的影响()
     
分享到：

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第10卷
期数:
2017年12期
页码:
1423-1427
栏目:
论著
出版日期:
2017-12-06

文章信息/Info

Title:
Effects of Baoshen Tongluo recipe on urinary albumin and urinary nephrin、podocin excretion in early diabetic nephropathy rats
作者:
唐珑; 王悦芬; 赵文景; 孙雪艳; 崔方强; 孟元; 赵静; 蔡朕; 王晖; 申子龙
100010 首都医科大学附属北京中医医院肾病科[唐珑(硕士研究生)、王悦芬、赵文景、孙雪艳、崔方强、孟元、赵静、蔡朕、王晖、申子龙]
Author(s):
TANG Long; WANG Yuefen; ZHAO Wenjing; et al.
Department of Nephrology,Beijing Chinese Medicine Hospital Affiliated to Capital Medical University,Beijing100010,China
关键词:
糖尿病肾病;  保肾通络方;  尿Nephrin;  尿Podocin;  足细胞
Keywords:
Diabetic nephropathy;  Baoshen Tongluo recipe;  Urine nephrin;  Urine podocin;  Podocyte
分类号:
R587.1
DOI:
10.3969/j.issn.1674-1749.2017.12.002
文献标志码:
A
摘要:
目的 观察不同剂量的保肾通络方对早期糖尿病肾病大鼠尿蛋白、尿Nephrin、尿Podocin排泄的影响,探讨本方对糖尿病肾病的作用机制及最佳剂量。方法 将链脲佐菌素(streptozocin,STZ)建立的早期糖尿病肾病大鼠模型随机分为正常组、模型组及中药高、中、低剂量组。用药8周后,检测各组大鼠血糖、尿糖、尿白蛋白及尿Nephrin、Podocin的水平,并将尿Nephrin、Podocin的排泄浓度与尿白蛋白做相关性分析。结果 药物干预8周后,中药各剂量组大鼠的血糖、尿糖、尿白蛋白水平较模型组有降低趋势,但组间差异无统计学意义(P>0.05); 中药各剂量组大鼠尿Nephrin、Podocin排泄均低于模型组,其中中药中剂量组、中药高剂量组尿Nephrin排泄明显低于模型组(P<0.05),但二者组间差异无统计学意义(P>0.05); Pearson相关分析显示尿Nephrin、尿Podocin排泄呈正相关(r=0.517,P<0.05),且二者均与尿白蛋白水平呈正相关(r=0.746,P<0.05)。结论 保肾通络方对早期糖尿病肾病大鼠足细胞可能存在保护作用,其中对尿Nephrin排泄的影响可能先于尿白蛋白出现。
Abstract:
Objective To observe the effects of different doses of Baoshen Tongluo recipe on urinary protein, urinary nephrin、podocin excretion in early diabetic nephropathy rats, and investigate its protection of diabetic nephropathy and the optimal dose. Methods Early diabetic nephropathy rats model was induced by streptozotocin(STZ), and the rats were randomly divided into normal group, model group and different dose traditional Chinese medicine groups. After treatment for 8 weeks, blood glucose, urine glucose, urinary albumin and urinary excretion of nephrin、podocin were detected, and correlation analysis was conducted between the concentration of nephrin and podocin in urine and urinary albumin. Results After 8 weeks of drug intervention, the levels of blood glucose, urine glucose,urinary albumin in different dose of Chinese medicine group were lower than those of model group, but there were no significant differences among intervention groups(P>0.05). The urinary nephrin and podocin excretion in traditional Chinese medicine groups were lower than those in the model group, and the excretion of urinary nephrin in high and middle dose of traditional Chinese medicine groups were significantly lower than that of model group(P<0.05), but there were no differences between the high dose group and middle dose group of traditional Chinese medicine. Pearson correlation analysis showed that urinary nephrin, urinary podocin excretion was positively correlated(r=0.517, P<0.05), and two of them were positively correlated with urinary protein level(r=0.746, P<0.05). Conclusion Baoshen Tongluo recipe may have protective effect on glomerular podocyte in rats with early diabetic nephropathy, the effect on urinary nephrin excretion may be prior to urinary albumin excretion.

参考文献/References:

[1] Kawachi H, Miyauchi N, Suzuki K,et al.Role of podocyte slit diaphragm as a filtration barrier[J]. Nephrology,2006,11(4):274-281.
[2] Packham D K, Alves T P, Dwyer J P, et al. Relative Incidence of ESRD Versus Cardiovascular Mortality in Proteinuric Type 2 Diabetes and Nephropathy:Results From the DIAMETRIC(Diabetes Mellitus Treatment for Renal Insufficiency Consortium)Database[J].American Journal of Kidney Diseases,2012, 59(1):75-83.
[3] Bhattacharjee N, Barma S, Konwar N, et al. Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update[J]. European Journal of Pharmacology, 2016,791:8-24.
[4] Huang G, Lv J, Li T, et al. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway[J]. International Journal of Molecular Medicine, 2016, 38(4):1179-1189.
[5] Braun F, Becker J U, Brinkkoetter P T. Live or Let Die: Is There any Cell Death in Podocytes?[J]. Seminars in Nephrology, 2016, 36(3):208-219.
[6] Jha J C, Thallasbonke V, Banal C, et al. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy[J]. Diabetologia, 2016, 59(2):379-389.
[7] Li C, Siragy H M. High glucose induces podocyte injury via enhanced(pro)renin receptor-Wnt-β-catenin-snail signaling pathway[J]. Plos One, 2014, 9(2):e89233.
[8] Kandasamy Y, Smith R, Lumbers E R, et al. Nephrin-a biomarker of early glomerular injury[J].Biomarker Research,2014,2(1):21.
[9] Gluhovschi C, Gluhovschi G, Petrica L, et al. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy[J]. Journal of Diabetes Research,2016,(4):1-13.
[10] Sato Y, Wharram B L, Lee S K, et al. Urine podocyte mRNAs mark progression of renal disease[J]. Journal of the American Society of Nephrology Jasn, 2009, 20(5):1041-1052.
[11] Alter M L, Kretschmer A, Von W K, et al. Early urinary and plasma biomarkers for experimental diabetic nephropathy[J].Clinical Laboratory,2012,58(7-8):659-671.
[12] Nascimento J F D, Canani L H, Gerchman F, et al. Messenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathy[J]. BMC Nephrology,2013,14(1):214.
[13] Zheng M, Lv L L, Ni J, et al. Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy[J]. Plos One,2011,6(5):20431.
[14] Wickman L, Afshinnia F, Wang S Q, et al. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases[J]. Journal of the American Society of Nephrology Jasn, 2013, 24(12):2081.
[15] 段昱方,蔡朕,赵文景,等.改良保肾方Ⅱ号治疗糖尿病肾病临床观察[J].辽宁中医药大学学报,2011,13(6):66-68.
[16] 蔡朕,郑桂敏,刘宝利,等.保肾通络方对糖尿病肾病大鼠肾脏病理和肾组织MMP-2/TIMP-2表达的影响[J].北京中医药,2010,6(29):452-455.
[17] 赵文景,张炳厚,刘宝利,等.加味补肾利湿汤配合虫类药治疗慢性肾炎蛋白尿的临床观察[J].北京中医药,2014,3(33):179-183.

相似文献/References:

[1]刘孝琴 王云枫 李雅楠.参芪地黄汤加味配合门冬胰岛素对早期2型糖尿病肾病 负氮平衡的影响[J].环球中医药,2013,6(05):366.
[2]王涵 周强 仝小林.仝小林治疗糖尿病并发症应用黄芪经验[J].环球中医药,2013,6(04):272.
[3]李光超 车念聪 耿建国等.加味消渴康对糖尿病肾病大鼠肝组织细胞外基质相关 调节因子表达的影响[J].环球中医药,2014,7(02):88.
　LI Guang chao,CHE Nian cong,GENG Jian guo,et al.The effects of JiaweiXiaokekang on the expressions of factors regulating the hepatic extracellular matrix in DN rats[J].,2014,7(12):88.
[4]郑洪光,李秀兰,石燕萍,等.糖尿病肾病130例中医证型分类研究[J].环球中医药,2012,5(10):783.
[5]齐铮,赵进喜,王硕仁,等.糖尿病肾病中医证候分布规律的文献研究[J].环球中医药,2012,5(12):914.
　QI Zheng,ZHAO Jin-xi,WANG Shuo-ren,et al.Distribution regules on syndrone of diabetic nephropathy[J].,2012,5(12):914.
[6]周盛楠 高彦彬 李娇阳等.通心络对早期糖尿病肾病大鼠肾功能及肾组织NO/eNOS表达的影响[J].环球中医药,2014,7(11):821.
　ZHOU Sheng-nan,GAO Yan-bin,LI Jiao-yang,et al.Effects of Tong Xinluo on renal function and NO/eNOS expression in kidney in DN rats[J].,2014,7(12):821.
[7]邹大威,高彦彬,李娇阳,等.糖肾宁对糖尿病肾病大鼠肾组织nephrin、desmin表达的影响[J].环球中医药,2015,8(03):307.[doi:10.3969/j.issn.1674-1749.2015.03.011]
　ZOU Da-wei,GAO Yan-bin,Li Jiao-yang,et al.Effects of Tangshenning on nephrin, desmin expression of renal tissue in STZ-Induced diabetic rats[J].,2015,8(12):307.[doi:10.3969/j.issn.1674-1749.2015.03.011]
[8]熊燕.余江毅教授治疗糖尿病肾病经验[J].环球中医药,2015,8(04):474.[doi:10.3969/j.issn.1674-1749.2015.04.028]
[9]邹大威,高彦彬,刘迎新,等.糖肾宁对自发性2型糖尿病KKAy小鼠肾组织MMP9、TIMP1表达的影响[J].环球中医药,2015,8(11):1324.[doi:10.3969/j.issn.1674-1749.2015.11.013]
　ZOU Da wei,GAO Yan bin,LIU Ying xin,et al.Effects of Tangshenning on MMP9、TIMP1 expression of renal tissue in type 2 diabetic KKay mice[J].,2015,8(12):1324.[doi:10.3969/j.issn.1674-1749.2015.11.013]
[10]申子龙,赵进喜,王颖辉,等.基于因子分析的早期糖尿病肾病证候要素研究[J].环球中医药,2016,9(02):129.[doi:10.3969/j.issn.1674-1749.2016.02.001]
　SHEN Zi-long,ZHAO Jin-xi,WANG Ying-hui,et al.Study on the syndrome characteristics of early diabetic nephropathy based on the factor analysis[J].,2016,9(12):129.[doi:10.3969/j.issn.1674-1749.2016.02.001]

备注/Memo

备注/Memo:
基金项目: 中医络病研究北京市重点实验室
作者简介: 唐珑(1989- ),女,2015级在读硕士研究生,住院医师。研究方向:中医肾病。E-mail: tangxh1989@sina.cn
通信作者: 赵文景(1969- ),女,博士,主任医师,硕士生导师。研究方向:中医肾病。E-mail:54498878@qq.com
更新日期/Last Update: 2017-11-06